Theralase Technologies Inc. V.TLT

RE:RE:Converting IR to CR

[CancerSlayer]

CancerSlayer wrote:

Kingpin68 wrote: The last update was about IR's that were converted to CR's based on further assessment, ie, bladder biopsy. The company also stated that they have more such assessments to have done on IR's. So hopefully more IR's may also convert to CR.
It's looking good people, and shares are still so unbelievably cheap.

 

Of more interest to me is that there were 5 of 17 90 day NRs who became with IR or CR on their 180 day assessments.  The trend so far demonstrates that the NRs who convert, their conversion lasts only for a brief period of time.  This suggests to me that the immune response varies & it can take more time to kick in & show its colors (hehe) for some patients.  This "delayed" response, however, may not be enough for these patients to completely rid their cancer, or at least keep their cancer in check.  

The above trend suggests to me (disclosure: an older brain) that perhaps in some patients, an additional/3rd timely treatment may help keep these patients in remission (complete or partial).  There were also 7 patients determined to be CR at 90 days who eventually became NR on at least two consecutive assessments, suggesting they will likely remain NR, but also raising the possibility that an additional/3rd treatment could ultimately provide added benefit?  All imo.

Aside from the obvious advantages of our two-treatment protocol, such a simpler protocol could potentially allow a practitioner more treatment "wiggle room" for a patient population that appears to be more treatment-resistant or has undergone significant pretreatment.  Such treatment agility would be difficult to extend to the other approved/under study treatments, where the pervasive theme seems to be...."many" more is better.
JMHO.  Good luck...

 

Old brain correction:  

Of more interest to me is that there were 5 of 17 90 day NRs who became IR or CR on their 180 day assessments.